Scilex Holding Company (SCLXW)

USD 0.21

(-23.88%)

Total Debt Summary of Scilex Holding Company

Scilex Holding Company's latest annual total debt in 2023 was 128.46 Million USD , up 9010.85% from previous year.
Scilex Holding Company's latest quarterly total debt in 2024 Q1 was 112.04 Million USD , down -12.78% from previous quarter.
Scilex Holding Company reported annual total debt of 1.41 Million USD in 2022, down -99.09% from previous year.
Scilex Holding Company reported annual total debt of 154.74 Million USD in 2021, up 11.63% from previous year.
Scilex Holding Company reported quarterly total debt of 106.99 Million USD for 2024 Q2, down -4.51% from previous quarter.
Scilex Holding Company reported quarterly total debt of 10.83 Million USD for 2023 Q1, up 668.37% from previous quarter.

Annual Total Debt Chart of Scilex Holding Company (2023 - 2020)

Historical Annual Total Debt of Scilex Holding Company (2023 - 2020)

Year	Total Debt	Total Debt Growth
2023	128.46 Million USD	9010.85%
2022	1.41 Million USD	-99.09%
2021	154.74 Million USD	11.63%
2020	138.62 Million USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	112.04 Million USD	-12.78%
2024 Q2	106.99 Million USD	-4.51%
2023 Q1	10.83 Million USD	668.37%
2023 Q3	125.34 Million USD	232.25%
2023 FY	128.46 Million USD	9010.85%
2023 Q4	128.46 Million USD	2.49%
2023 Q2	37.72 Million USD	248.22%
2022 FY	1.41 Million USD	-99.09%
2022 Q2	4.03 Million USD	99.15%
2022 Q3	111.4 Million USD	2661.76%
2022 Q4	1.41 Million USD	-98.73%
2022 Q1	2.02 Million USD	319.29%
2021 Q2	38.27 Million USD	0.0%
2021 Q1	38.27 Million USD	12.12%
2021 Q3	38.27 Million USD	0.0%
2021 FY	154.74 Million USD	11.63%
2021 Q4	483.09 Thousand USD	-98.74%
2020 Q3	34.13 Million USD	0.0%
2020 Q4	34.13 Million USD	0.0%
2020 FY	138.62 Million USD	0.0%
2020 Q2	34.13 Million USD	0.0%
2020 Q1	34.13 Million USD	0.0%

Peer Total Debt Comparison of Scilex Holding Company

Name	Total Debt	Total Debt Difference
Amgen Inc.	64.61 Billion USD	99.801%
AstraZeneca PLC	28.62 Billion USD	99.551%
Biogen Inc.	7.33 Billion USD	98.249%
Gilead Sciences, Inc.	24.98 Billion USD	99.486%
MIRA Pharmaceuticals, Inc.	5061.00 USD	-2538192.828%
Scilex Holding Company	128.46 Million USD	0.0%